Rachel E. Rempel

5.0k total citations · 1 hit paper
37 papers, 3.0k citations indexed

About

Rachel E. Rempel is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rachel E. Rempel has authored 37 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Rachel E. Rempel's work include Cancer-related Molecular Pathways (11 papers), Immune Cell Function and Interaction (7 papers) and Epigenetics and DNA Methylation (5 papers). Rachel E. Rempel is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Immune Cell Function and Interaction (7 papers) and Epigenetics and DNA Methylation (5 papers). Rachel E. Rempel collaborates with scholars based in United States, Singapore and Australia. Rachel E. Rempel's co-authors include James L. Maller, Paloma H. Giangrande, Bruce A. Sullenger, Eran R. Andrechek, James O McNamara, Kristi D. Viles, Yong Wang, Eli Gilboa, Paula Traktman and Joseph R. Nevins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Rachel E. Rempel

34 papers receiving 2.9k citations

Hit Papers

Cell type–specific delivery of siRNAs with aptamer-siRNA ... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel E. Rempel United States 21 2.3k 760 405 388 347 37 3.0k
Elaine M. Taylor United Kingdom 18 1.6k 0.7× 301 0.4× 264 0.7× 242 0.6× 293 0.8× 25 1.9k
Maureen E. Hoatlin United States 30 3.5k 1.5× 610 0.8× 473 1.2× 755 1.9× 1.1k 3.2× 56 3.9k
Han Xu United States 21 3.1k 1.3× 403 0.5× 163 0.4× 528 1.4× 526 1.5× 44 3.7k
Elizabeth L. Evans United States 23 1.7k 0.7× 299 0.4× 183 0.5× 314 0.8× 391 1.1× 36 2.6k
Elias Coutavas United States 21 2.7k 1.1× 523 0.7× 546 1.3× 288 0.7× 97 0.3× 28 3.3k
Olaf Heidenreich United Kingdom 36 3.0k 1.3× 613 0.8× 146 0.4× 299 0.8× 491 1.4× 136 4.1k
Christian Hagemeier Germany 33 2.1k 0.9× 924 1.2× 145 0.4× 622 1.6× 329 0.9× 59 3.7k
Vincent Moncollin France 25 3.9k 1.7× 873 1.1× 331 0.8× 709 1.8× 535 1.5× 38 4.5k
Annette M.G. Dirac Netherlands 17 3.7k 1.6× 1.2k 1.6× 477 1.2× 473 1.2× 811 2.3× 18 4.3k
F W Alt United States 28 2.9k 1.3× 761 1.0× 233 0.6× 768 2.0× 352 1.0× 33 4.8k

Countries citing papers authored by Rachel E. Rempel

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Rempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Rempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Rempel more than expected).

Fields of papers citing papers by Rachel E. Rempel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Rempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Rempel. The network helps show where Rachel E. Rempel may publish in the future.

Co-authorship network of co-authors of Rachel E. Rempel

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Rempel. A scholar is included among the top collaborators of Rachel E. Rempel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Rempel. Rachel E. Rempel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Haixiang, George A. Pitoc, James W. Frederiksen, et al.. (2025). An Aptamer‐Based EXACT Anticoagulant as a Sustainable, Animal‐Free Alternative to Unfractionated Heparin. Advanced Science. 13(4). e09867–e09867.
2.
Yu, Haixiang, James W. Frederiksen, George A. Pitoc, et al.. (2024). Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors. Nature Communications. 15(1). 3977–3977. 6 indexed citations
3.
Gray, Bethany Powell, Juliana M. Layzer, Rachel E. Rempel, et al.. (2023). Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes. Molecular Therapy — Nucleic Acids. 31. 440–451. 5 indexed citations
4.
Olson, Lyra B., et al.. (2022). Targeting DAMPs with nucleic acid scavengers to treat lupus. Translational research. 245. 30–40. 9 indexed citations
5.
Olson, Lyra B., Rachel E. Rempel, Haixiang Yu, et al.. (2022). Mixed-surface polyamidoamine polymer variants retain nucleic acid-scavenger ability with reduced toxicity. iScience. 25(12). 105542–105542. 2 indexed citations
6.
Olson, Lyra B., Rachel E. Rempel, Jeffrey I. Everitt, et al.. (2021). β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes. Molecular Therapy. 30(2). 845–854. 9 indexed citations
7.
Naqvi, Ibtehaj A., Ruwan Gunaratne, Jessica E. McDade, et al.. (2018). Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Molecular Therapy. 26(4). 1020–1031. 47 indexed citations
8.
Rempel, Rachel E., Tuan Zea Tan, Jieru Ye, et al.. (2014). Utilization of the Eμ-Myc Mouse to Model Heterogeneity of Therapeutic Response. Molecular Cancer Therapeutics. 13(12). 3219–3229. 9 indexed citations
9.
Rempel, Rachel E., Seiichi Mori, Maura Gasparetto, et al.. (2009). A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis. PLoS Genetics. 5(9). e1000640–e1000640. 19 indexed citations
10.
Mori, Seiichi, Rachel E. Rempel, Jeffrey T. Chang, et al.. (2008). Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the Eμ- myc Model and Human Diffuse Large B-Cell Lymphoma. Cancer Research. 68(20). 8525–8534. 56 indexed citations
11.
Giangrande, Paloma H., Jianxin Zhang, Alice Tanner, et al.. (2007). Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proceedings of the National Academy of Sciences. 104(32). 12988–12993. 35 indexed citations
12.
Giangrande, Paloma H., et al.. (2004). Combinatorial gene control involving E2F and E Box family members. The EMBO Journal. 23(6). 1336–1347. 61 indexed citations
13.
Leone, Gustavo, Rosalie C. Sears, Erich Huang, et al.. (2001). Myc Requires Distinct E2F Activities to Induce S Phase and Apoptosis. Molecular Cell. 8(1). 105–113. 208 indexed citations
14.
Gaubatz, Stefan, Geoffrey J. Lindeman, Seiichi Ishida, et al.. (2000). E2F4 and E2F5 Play an Essential Role in Pocket Protein–Mediated G1 Control. Molecular Cell. 6(3). 729–735. 229 indexed citations
15.
Hartley, Rebecca S., Rachel E. Rempel, & James L. Maller. (1996). In VivoRegulation of the Early Embryonic Cell Cycle inXenopus. Developmental Biology. 173(2). 408–419. 133 indexed citations
16.
Strausfeld, Ulrich, Michael Howell, Patrick Descombes, et al.. (1996). Both cyclin A and cyclin E have S-phase promoting (SPF) activity in Xenopus egg extracts. Journal of Cell Science. 109(6). 1555–1563. 123 indexed citations
17.
Rempel, Rachel E., et al.. (1995). Maternal Xenopus Cdk2-Cyclin E Complexes Function during Meiotic and Early Embryonic Cell Cycles That Lack a G1 Phase. Journal of Biological Chemistry. 270(12). 6843–6855. 128 indexed citations
18.
Hicke, Brian J., Rachel E. Rempel, Richard A. Swank, et al.. (1995). Phosphorylation of theOxytrichatelomere protein: possible cell cycle regulation. Nucleic Acids Research. 23(11). 1887–1893. 12 indexed citations
19.
Strausfeld, Ulrich, Michael Howell, Rachel E. Rempel, et al.. (1994). Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Current Biology. 4(10). 876–883. 120 indexed citations
20.
Paynton, Barbara V., Rachel E. Rempel, & Rosemary F. Bachvarova. (1988). Changes in state of adenylation and time course of degradation of maternal mRNAs during oocyte maturation and early embryonic development in the mouse. Developmental Biology. 129(2). 304–314. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026